PEG-Intron pegylated interferon-alpha-2b regulatory update

ENZN partner Schering-Plough Corp. (SGP, Kenilworth, N.J.) submitted a supplemental BLA to the FDA for

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE